Protagonist Therapeutics Inc. (PTGX)
Market Open
8 Dec, 19:54
NASDAQ (NMS) NASDAQ (NMS) Primary 
XBER $
90. 56
+0.91
+1.02%
$
5.63B Market Cap
- P/E Ratio
0% Div Yield
355,340 Volume
0.75 Eps
$ 89.65
Previous Close Day Range
89.73 91.07
Year Range
33.7 93.25
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 74 days
Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024
NEWARK, CA / ACCESSWIRE / July 22, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D.
Accesswire | 1 year ago
Protagonist Therapeutics (PTGX) is on the Move, Here's Why the Trend Could be Sustainable
If you are looking for stocks that are well positioned to maintain their recent uptrend, Protagonist Therapeutics (PTGX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Zacks | 1 year ago
2025 © Marketlog. All Rights Reserved.
